Displaying publications 1 - 20 of 544 in total

Abstract:
Sort:
  1. Ng PK
    Family Practitioner, 1982;5:86-87.
    Matched MeSH terms: Fever
  2. Purvis GB
    Trans R Soc Trop Med Hyg, 1931;24:651-654.
    Matched MeSH terms: Fever
  3. Fletcher W
    Trans R Soc Trop Med Hyg, 1935;29:111-112.
    DOI: 10.1016/S0035-9203(35)90047-5
    Matched MeSH terms: Fever
  4. The Ambulatory PS
    Family Physician, 1995;7:40-41.
    Matched MeSH terms: Fever
  5. Gurdeep PS
    Family Practitioner, 1984;7:20-22.
    Matched MeSH terms: Fever; Typhoid Fever
  6. Lewthwaite R
    Matched MeSH terms: Fever
  7. Lewthwaite R
    Lancet, 1940;235:390.
    DOI: 10.1016/S0140-6736(00)61502-7
    Matched MeSH terms: Rat-Bite Fever
  8. Hennessy PH, Ford JCC
    Matched MeSH terms: Fever
  9. Singham KT
    Family Physician, 2000;11:14-15.
    Matched MeSH terms: Fever
  10. Ross I, Abraham T
    Med J Malaysia, 1986 Mar;41(1):51-2.
    PMID: 3796350
    Matched MeSH terms: Typhoid Fever/diagnosis*
  11. Gillett JD, Ross RW
    Ann Trop Med Parasitol, 1955;49:63-65.
    DOI: 10.1080/00034983.1955.11685652
    Matched MeSH terms: Yellow Fever; Yellow Fever/transmission
  12. Smith CE
    Matched MeSH terms: Typhoid Fever
  13. Lim Teong Wah
    Med J Malaya, 1965 Mar;19(3):188-90.
    PMID: 4220471
    Matched MeSH terms: Paratyphoid Fever/immunology*; Typhoid Fever/immunology*
  14. Lee KW, Yap SF, Ngeow YF, Lye MS
    PMID: 33808066 DOI: 10.3390/ijerph18073554
    COVID-19 is a global health emergency. People living with human immunodeficiency virus (PLHIV) have concerns about whether they have a higher risk of getting the infection and suffer worse COVID-19 outcomes. Findings from studies on these questions have largely been inconsistent. We aimed to determine the epidemiological characteristics, clinical signs and symptoms, blood parameters, and clinical outcomes among PLHIV who contracted COVID-19. Relevant studies were identified through Medline, Cinahl, and PubMed databases. A random-effects model was used in meta-analyses with a 95% confidence interval. Eighty-two studies were included in the systematic review and sixty-seven studies for the meta-analysis. The pooled incidence proportion of COVID-19 among PLHIV was 0.9% (95% CI 0.6%, 1.1%) based on the data from seven cohort studies. Overall, 28.4% were hospitalised, of whom, 2.5% was severe-critical cases and 3.5% needed intensive care. The overall mortality rate was 5.3%. Hypertension was the most commonly reported comorbidity (24.0%). Fever (71.1%) was the most common symptom. Chest imaging demonstrated a wide range of abnormal findings encompassing common changes such as ground glass opacities and consolidation as well as a spectrum of less common abnormalities. Laboratory testing of inflammation markers showed that C-reactive protein, ferritin, and interleukin-6 were frequently elevated, albeit to different extents. Clinical features as well as the results of chest imaging and laboratory testing were similar in highly active antiretroviral therapy (HAART)-treated and non-treated patients. PLHIV were not found to be at higher risk for adverse outcomes of COVID-19. Hence, in COVID-19 management, it appears that they can be treated the same way as HIV negative individuals. Nevertheless, as the pandemic situation is rapidly evolving, more evidence may be needed to arrive at definitive recommendations.
    Matched MeSH terms: Fever
  15. Dunlop GA
    Matched MeSH terms: Fever of Unknown Origin
  16. Robertson M
    Matched MeSH terms: Rheumatic Fever
  17. von Tunzelmann EW
    Matched MeSH terms: Fever
Filters
Contact Us

Please provide feedback to Administrator (tengcl@gmail.com)

External Links